Epstein Secrets

From: Boris Nikolic To: "Jeffrey Epstein ([email protected])" <[email protected]> Subject: FW: Materials at request of David Rubenstein Date: Fri, 29 Apr 2011 00:09:44 +0000 Attac

From: Boris Nikolic To: "Jeffrey Epstein ([email protected])" <[email protected]>

From: Boris Nikolic To: "Jeffrey Epstein ([email protected])" <jeevacation@gma

that end I'd be happy to meet with you in Seattle (or elsewhere) if that would be desirable and would facilitate a discussion. Best regards, Ryan Ryan M. Schwarz Managing Director THE CARLYLE GROUP From: Boris Nikolic [mallto: Sent: Friday, March 11, 2011 2:21 AM To: Ryan Schwarz Subject: RE: Materials a

From: Boris Nikolic To: "Jeffrey Epstein (I < Subject: FW: Materials at request of David Rubenstein Date: Tue, 04 Feb 2014 07:51:42 +0000 Attachments: NaviMed_Global_PPM_Draft_4-18-11_pd

From: Boris Nikolic To: "Jeffrey Epstein (I < Subject: FW: Materials at request of David

From: Boris Nikolic To: "Jeffrey Epstein (I < Subject: FW: Materials at request

o that end • be happy to meet with you in Seattle (or elsewhere) if that would be desirable and would facilitate a discussion. Best regards, Ryan Ryan M. Schwarz Managing Director THE CARLYLE GROUP 1001 Pennsylvania Ave. =. Washington, DC 20004 direct mobile From: Boris Nikolic [mailto: Sent: Friday, Ma

From: Boris Nikolic To: "Jeffrey Epstein I III ) " Subject: FW: Materials at request of David Rubenstein Date: Fri, 11 Mar 2011 03:17:41 +0000 Attachments: NaviMed_Global Health Partners

From: Boris Nikolic To: "Jeffrey Epstein I III ) " Subject: FW: Materials at request of D

From: Boris Nikolic To: "Jeffrey Epstein I III ) " Subject: FW: Materials at requ

ity that we are pursuing involving Xigris, the sole approved, on-market drug for severe sepsis. I look forward to seeing you in the morning. Ryan Ryan M. Schwarz Managing Director THE CARLYLE GROUP 1001 Pennsylvania Ave. =. Washington, DC 20004 202-347-2626 202-347-1818 fax 202-729-5334 direct 202-285-